Science topic
Nano Biomedicine - Science topic
Explore the latest questions and answers in Nano Biomedicine , and find Nano Biomedicine experts.
Questions related to Nano Biomedicine
1-The conditions of the relationship between the pigment (Pyocyanin) with Gold (Au Nanoparticles)?
2-Dose the pigment (Pyocyanin) work as Reducing agent or not?
3-Dose the pigment (Pyocyanin) endures high temperatures or not?
Hi everyone!
I'm trying to produce a nanocapsule using TCM, Span 80 and Tween 80 (1:2:2 ratio) and PCL (100 mg). However, when I transfer the organic phase to the aqueous phase (interfacial deposition of preformed polymer), the PCL precipitates (no matter the parameters, i.e., temperature, rotation, etc.).
(This apply to the blank nc and the compound nc).
Does anyone have any insights?
Thanks in advance!
I want make silica coated magnets but I have several problem in procedure. I cant make high quality silica coated magnets.
Results show a poor yield so i think many of magnets don't be coated.
How can i increase silica coated magnets or how can i increase coating with silica?
How can i separate silica coated magnet and non coated magnets ?
What is the best protocols to produce silica coated magnets?
I have synthesized mesoporous silica nanoparticles and removed the CTAB via ethanol. Can this ethanol be used again for the removal of CTAB from another batch of mesoporous silica nanoparticles or using fresh ethanol is preferred each time?
I'd be grateful for your guidance
Starting from the genetic sequence of an mRNA, is it possible to allow the self-assembly of graphene nanoparticles (GQD - Graphene Quantum Dots), in such a way as to obtain certain circuits, with the formation of specific electronic components at the nanoscale? With what correlation between the triplets and the electronic scheme?
Thank you.
Nanoparticles have been extensively studied in the field of drug loading and toxicology. Although the size of nanoparticles is an important nature that affects their behavior in vivo , I have not found appropriate method to measure their size in physiological fluids ? Which method is better for analyzing physiological fluids?( e.g. DLS, TEM/SEM, NTA , AFM ...)
I mainly want to konw is whether the size of nanoparticls changes or not as they enter the body.
Hi.
We have some carbon nanoparticles and want to check antibacterial activity against drug-resistant bacteria. Before working on drug-tolerant bacteria, Are there any protocols or parameters for checking nanoparticles whether have the antibacterial capability on drug-resistant bacteria?.
Hi.
I have prepared hetero-atom-doped carbon dots (Nitrogen with sulfur, boron, phosphorous) for the eradication of biofilm of drug-resistant bacteria. But, I did not see any bacterial death at low concentrations when I am using doped carbon dots. Should I change any parameters or something else?
I have synthesized carbon dots that exhibit fluorescent properties, that are further coated with PEG through EDC. I want to separate them through gel electrophoresis based on the number of PEG attachment. Is the gel electrophoresis for Carbondots any different than gel electrophoresis for nucleic acids ?
Hello, can anyone please named few potential drug delivery technologies that you think are novel and unique. Our comapny is looking to buy few drug delivery technologies that can serve us to compete for now and few next years. Suggestions are highly appreciated. Thanks in advance.
Regards
I know there are many reasons why bacteria are multi-drug resistant, but I want to know your opinion on which one is the primary cause of this problem.
I'm conducting research on this problem right now so your help is appreciated.
I have biofunctionalized o-MWCNT with 2 recombinant proteins; the proteins had 10 histidine tags to attach to the o-MWCNT. After dispersing in media (without serum) to incubate with cells less than 24h o-MWCNT intensively aggregate (37C incubator). I have changed the media (less glucose and salt) and tried to improve biofunctionalization (for better coating), although the measures were inefficient.
Does the downsizing affect the pore size or pore number in the nanoMOFs?
I know that the nanoMOFs retain their crystalline structures as their bulk parents, and for example, if we reduce the size of a bulk MOF to smaller than 10 nm, it's surface area will increase, but for meso MOFs with pore size of 2 nm or more (PCN-224, for example), How will be the porosity? Could be possible to produce such nanoscale meso MOFs?
I have collected 6h to 96h drug release data for unilamellar liposomal vesicle by using spectrophotometer. According to data, we have encapsulated chemotherapeutic agent in 80% efficiency. But when we look at the release profile, liposomes do release the drug at minimum level even at the 96h. Is it possible ? What are the reasons behind that ? Is minimum releasing okay ? What are the consequences of this thightly encapsulation ?
I could not synthesize Selenium nanoparticles by PEG 200 at up-scale ( more than 100 ml) as it got aggregated while at small amounts it works fine , I work with 850 PPM using selenium powder in PEG 200 heated to around 200 degree. What is the problem?
I'm trying to make Nanostructured lipid carriers (NLC) using ultrasonicator method for cancer meds that are hydrophobic and insoluble in water. I'm heating solid and liquid lipid phase and then adding meds to it and then slowly adding aqueous phase to it which consists of water and poly 80.
Then I sonicate this mixture in ultrasound sonicator to generate nanoparticles.
My question is, does reducing size and encapsulation in lipid increase absorption and bioavailability against cancer cells? I'm not using any solvents. Do I need to? Shouldn't the insoluble drug essentially become soluble once it's particle size is reduced by ultrasonicator ?
Please help. Thanks a lot.
Hi everybody: i am looking for recent datas about the amount of registered biocides containing silver nanoparticles. The most recent data i found is in this paper from Nowack et al. (2011) which explains that about the 53% of biocides registered at EPA contains nanoAg and the 7% of it contains AgNPs. I looked for more recent datas/numbers about biocides cointaining nanoAg/AgNPs, but from main sites like EPA's, REACH's and ECHA's or from the huge amount of papers i read nothing came out. I was wondering if someone has something (papers, reviews, sites etc..) to share with me to help my research. Everything is accepted but it must be referred to biocides containing nanoAg/AgNPs.
Thanks a lot to everyone who will share his/her time with me
Mattia
Hi, I'm trying a procedure to synthesis nano ZIF-90 in water for specific application, but there is some problem. pxrd pattern for as-synthesized MOF is not completely compatible with charactristic XRD pattern of ZIF-90, in terms of tetha. on the other side, as article indicated, i choose 1 to 40 ratio of zinc acetate to 2-imidazole carboxaldehyde to obtain particles with the scale of 100 nm, but led to really low yield, there is not another way to reach nanosize ZIF-90? I appreciate if anyone has the same experience and could help me.
Ethylenediamine is attached to the surface of iron oxide nanoparticles via electrostatic interactions, what the effects of inhaling a very small quantity of these nanoparticles may be? Pure ethylenediamine is toxic, but it would exert its toxicity for as long as the nanoparticles stay in the lungs or weak bond would be broken,leaving only the naked iron oxide nanoparticles?
Resistant microorganisms (including bacteria, fungi, viruses and parasites) are able to withstand attack by antimicrobial drugs, such as antibacterial drugs (e.g. antibiotics), antifungals, antivirals, and antimalarials, so that standard treatments become ineffective and infections persist, increasing the risk.
It is an increasingly serious threat to global public health that requires action across all government sectors and society.Antimicrobial resistance is present in all parts of the world. New resistance mechanisms emerge and spread globally.
Can someone Provide/share some innovative ideas to combat AMR
We want to determine the antioxidant effects of our prepared formulation of nanoparticles by DPPH method. Our formulation is having some col and different excipients/vehicles. Please also tell how to compare the results with the bulk form of our compound.
Hi dear researchers
Is it possible that observed increase of Km for one substrate and decrease for another one (for enzymes with two substrates such as HRP) after immobilization?
What are the most promising fields of nanomedicine? In essence, how can applications of nanotechnology in the medical field revolutionize the current health standards?
I need some articles presenting nanoparticles use for gene therapy in details. In addition, their synthesis and mechanism of action.
Thanks in advance
What do you think are the major barriers or causes which stop nano particles from entering into mainstream treatment of lethal diseases in spite of success at lab scale?
Mathematical and computational methods are expected to play a major role in nanoscience and nanoengineering. Mathematics and computation can provide effective theory and simulations for analysis and interpretation of experimental results, model-based prediction of nanoscale phenomena, and design and control of nanoscale systems.
Whether its Silver nano particles or Au nanoparticles?
we may faced problem in removing plant extract from silver nano particles. If we check pharmacological activity as such we may not able to discuss the exact mechanism by which these particles show the activity.
How to make fun of what you have if you are uneducated and have non-academic skills to become a successful researcher?
i have to make nano size phtocatalyst that is Fe doped Tio2...kindly tell me how to prpare x mol % or wt % of fe-tio2...means how many grams or moles of fe and tio2 are required to make x mol % or wt %..here x=0.01, 0.05 mol % or wt %?
Hi,
There are many studies about functionalizing different ZnS nanostructures. but i couldn't find anything about ZnS nanotube. Is it possible, at all?
would you please share me your experiences? is there any theoretical or experimental studies about it?
Best
DNA is a polymer whose repeating unit contains a phosphate group (PO4), a ribose ring, and a DNA base, which can be either Adenine (A), Thymine (T), Guanine (G), or Cytosine (C); the phosphate group and ribose ring don't vary. The Carbon atoms in the base are numbered 1 through however many that base has, and those in the ribose are numbered 1' through 5'. The 5' carbon of the ribose ring is covalently bonded to one of the oxygens of the phosphate group, while the 3' carbon of the ribose ring is bonded to (a different) one of the oxygens of the next phosphate group; hence biologists commonly refer to the "5' end" and "3' end" of a DNA strand. The phosphate at the 5' end of a strand "normally" just won't have anything bound to it (although sometimes the 5' end of a DNA or RNA strand will get modified for the purpose of some cellular process); while 3' carbon of the base at the 3' end of a strand will have an OH group instead of the O of the next phosphate.
I am trying to determine the best possible method to measure the impedance on my monolayer of MDCK (Madin Darby Canine Kidney) epithelial cells.
Does this require a specific metallic coating (via sputter coater or another method) on/ under (as a membrane the cells would grow on) my monolayer or would the liquid media itself simple provide the conductive element required?
Dear all,
I want to run the molecular dynamics simulation of an infinite graphene sheet solvated in water using NAMD code. I don't know how to create an infinite sheet with it's periodic images. Should I add bonds between graphene and it's periodic images or is not needed?
Would be so much thankful to help me..
All the Best,
Zeynab
Drug release study requires taking absorbance of samples at absorption maxima (Lambda max) of drug. What should be the approach in case of poly herbal formulation (nanogel). There are atleast 5 active components in the nanogel with different absorption maxima.
In this case, at what lambda max should the absorbance be taken?
Recently, many reports have shown the adjuvant effect of ZnO nanoparticles or nanowires.
Some are showing good immunotherapeutic effects also. I am curious if anyone can help me to find out how ZnO is assisting the immune system.
I mean is there any specific mechanism?
Nanotechnology is an emerging technology for fabricating nanostructures where at least one dimension is smaller than 100 nm.
The development of easy, low-cost and high-throughput techniques for the fabrication of nanostructures has been of great interest for both the possibility to increase the device packing density and for reducing the power consumption, as well as the creation of a new class of nano-electronic devices
Dear all,
I'm very interested in synthesis and surface modification of iron oxide nanoparticles for biomedical applications.
Recently, I developed a amine-rich iron oxide nanoparticles and confirmed their perfect dispersion in 0.9 wt.% saline right after the purification process, however they have precipitated within a week.
As I understood, even the strongly-bound surface capping agents have their own dissociation constant. Such thing never happened in only PEG-coated nanoparticle, thus I guess the detached amine ligands were failed to re-bind with the nanoparticle surfaces due to the electrostatic charge interaction with anions.
Please give any idea or helpful references for better understandings :)
how can I study the encapsulation efficiency of essential oil loaded chitosan nanoparticles via GC or UV-VIS?
Hello,
I have a very peculiar bioanalyzer ladder result from a RNA Nano run. Has anyone ever seen anything like this? Currently I think this may be have to do with a lack of pressure in the chip priming station as after the 30s when I released the plunger from the clip, the plunger returned very quickly to almost the 1ml mark. Another possibility might be insufficient denaturation of the ladder?
Any input would be appreciated.
Hi, I am trying to obtain HOOC–PEG–COOH by oxidizing HO–PEG–OH in the presence of KMnO4 as oxidizer. I dissolved 5 g PEG-OH and 10 g KMnO4 in 50 ml dH2O and stirred overnight. Then I added 10 ml HCl, then again stirred. The next day I filtered out and obtained black precipitate. I characterized by FTIR, but I did not see HOOC–PEG–COOH. Then I changed my procedure; I dissolved 5 g PEG-OH in 25 ml NaOH, and 10 g KMnO4 in 125 ml dH2O. Then I added KMnO4 on PEG and stirred overnight. The next day I filtered out and obtained transparent solution. I added HCl on solution until pH=2, then again stirred a few minutes. Still, there is a problem.
Please, could anyone suggest me a protocol to oxidize HO–PEG–OH with KMnO4? Also, I have problems to purify HOOC–PEG–COOH.
Sincerely,
thank you for all
I want to coat a PLGA nano-capsule with Chitosan and TMC and Mannosilated Chitosan, but after centrifuge the coated nano particle size increased.
centrifuge details: 20000g for 5 min with glycerin bed in falcons.
3 hour steered in 10cc PVA 0.3% to evaporate organic phase and particle hardening.
size before centrifuge: Z- average 260 nm PdI 0.234
size after centrifuge: Z- average 2350 nm PdI 0.583
in another try i changed the centrifuging as below:
centrifuge details: 10000g(8500rpm) for 10 min with glycerin bed in falcons.
3 hour steered in 10cc PVA 0.3% to evaporate organic phase and particle hardening.
size before centrifuge: Z- average 250 nm PdI 0.230
size after centrifuge: Z- average 2116 nm PdI 0.583
so again i had aggregation.
Please suggest major chemical species available in the leaf extract, responsible for reduction of Ag nitrate to Ag NPs.
The drug is hydrophobic . The solubility of drug is less than 0.5 mg/ml in water, methanol and ethanol. But drug has very good solubility in DMSO. Is it good to use DMSO as the only solvent to load the drug in nanoparticles? How to remove DMSO completely from nanoparticles? The combination of 10% DMSO and 90 % water is correct or wrong?
I am working on nanoparticles for the treatment of cancer. I am working with hydrophobic and hydrophilic drug. usually people (in papers) use 24 hrs for loading of drug in nanoparticle. My question is that if we increase the loading time like 48 hrs, 72 hrs, 96 hrs etc drug loading in nanoparticle will increase or not? what are the factors that are important for loading of drug in nanoparticle?
I need to test the concentration- dependant uptake of nanoparticles. Can anyone give different options for hydroponic medium (both commercially available and composition for medium)
Decrease of surface to volume ratio in spherical nanoparticles led to red-shift in SPR diagram. But in same size nanoparticles, shape alteration, from sphere to cube, with respect to increase of surface to volume ratio, caused red-shift in SPR diagram. It means there are other factors could have an affect on the SPR.

darker color is equal bigger size always?
Nanoporous alumina surfaces will be incubated with solutions of individual proteins viz. albumin, laminin and fibronectin. Then trypsin will be used to digest the proteins to produce peptides that can be analyzed and quantified by MALDI-TOF mass spectrometry. It would be helpful to get some information/insight into the incubation time with trypsin and the procedure for peptide removal from the surfaces.
recent studies have focused on nanoparticles for anticancer treatment. are there any link between nanoparticles toxicity and heavy metal associated multiple organ failure ?
I want to synthesize nanofiber with diameter lesser than 10 nm which i further want to use as drug delivery system.
Please do tell me about the same.
Thanks in Advance
with the intention to delivery to lung alveoli for slow liposome release into systemic circulation?
Will EGCG be incorporated within the particle? If so, will it still be potent as an antioxidant or not? Please send me a source for further readings about green synthesis.
Dear all,
I'm studying on gold nanoparticle bioconjugation.
When I used EDC/NHS to gold nanoparticles, it aggregated, so I reacted these on ice to decrease the reaction temperature and used stabilizer.
At these point, I have a question.
Can EDC/NHS reaction occur below 4℃?
I have an odd data after I run my samples on zeta sizer. If I already labeled the vials correctly, is there any fact that can support my data? Mine is the hydrophobic drug of organotin compound encapsulated no some. The concentration of a drug is 10,25,50mM and surfactant is 1mM only.
Please help.
Hi All,
I am working on conjugating mAbs to the surface of PLGA-PEG-MAL nanoparticles. Free thiols are added to the mAbs using Traut's reagent, which will then be added to the NP suspension.
I am wondering if anyone has had experience with this conjugation and would advise me on which concentrations and ratios of mAbs and NPs would be best.
Any help would be wonderful.
Thank you!
EF
I dissolve the starch in water through probe sonicator for the preparation of silver nanoparticles. it dissolves easily but colour is changed from white to yellow. Does it affects the particles? Can anyone help?
Is the indirect method (free drug concentration in supernatant) considered as exact as the indirect one? which method one is more reliable?
i plotted % released vs time as release obeyed zero order kinetic, so how can i calculate time required for release 50% of drug content ( NB. i already have slope value = 6.004)
If we are using PBS as our release media and if the drug is not soluble in the media how can we study the release of that drug?
How to design nano-particulate system to which water soluble protein drugs may be encapsulated with a thermodynamically favoured process and with preserved native conformation??
Fe nanoparticles coated with polymer have been developed as drug carriers. Particle size <50 nm.
They are highly insoluble in organic solvents including DMSO or Ethanol.
Due to their solubility issue, their dilution is also a hassle.
We have tried sonicating the samples prior to dosing the cells.
Everytime the result is "nontoxic" even with dose as high as 2mg/ml.
I doubt that the nanoparticles are not interacting with the cells to manifest biological effects.
I want to know the silver conc in my AgNP Solution in PPM, which synthesized in laboratory.
I prepared chitosan nanoparticles some have got 0.2 and others are in the range of 0.4 - 0.5.
Hello dear colleagues;
Please anyone can help me with a simple way to coat iron based magnetic nano-particles after preparation? I already prepared the particles from glass crystallization and i want to test the bio-activity of these particles but i have a problem with agglomeration . I have tried once with PVA and I got a thin film after drying the polymer in vacuum oven. I want to dissolve these particles in NaCl to get injected in a mice blood. I want to now how to coat these particles with dextran and mix it with NaCl
We are interested in taking multiple CBFR measurements in a single rat using microspheres. The ideal protocol would involve administering microspheres at baseline and with dobutamine stimulation under control conditions, followed by washing out the dobutamine, administering our treatment, and repeating microsphere administration at baseline and with dobutamine. Being able to perform control and treatment measures in the same animal will save resources and help eliminate the influence of biological variability in our data. Has anyone attempted such a protocol before or come across any papers that use such a method? Thanks for any input!
Hi, I'm planning on adapting the methodology from this paper (http://www.nature.com/nprot/journal/v3/n2/full/nprot.2008.1.html) in order to produce a visual color change for the addition of an antigen to a solution of the conjugate (AuNP+Antibody).
I was wondering if
1. i could use a NH2-PEG-SH linker
2. whether the color change would be visible at those concentrations
3. if there is anyone who has any other advice or improvements
Thanks
The synthesized PEI-Dexamethasone were not dissolved after lyophilization. The reasones of this phenomena and the solutions, please.
I dont wish to use antigens for such targeting.
I am formulating a food supplement (nano-particle + papeine enzyme) that can be used as an alternative for those who are diagnosed with colorectal cancer that are MDR. Yes it can also be a "preventive measure". Genes of those with family history of colorectal cancers may also be prone to have liver or breast cancer, and yes, i am searching for a specific biodegradable nona-particle (to become a food supplement) that may be used to prevent cancers from worsening and/or occurring. Thank you for your help.
i have modified my nanoparticles with NH2 groups on the surface
I have prepared the lipid polymer hybrid nano particles using PLGA, lecithin and DSPE-PEG. Size of nano particle is around 80 nm. I want to know that how can i calculate the number of DSPE-PEG molecules forming a layer on the surface of nano particle?
I am doing cell viability test (WST-1) on THP-1 cell induced by nanoparticle. The % cell viabilty decrease until 32ug/ml but increase a little bit at higher concentration. Can anyone give me reasonable explaination for that? Thank you!
Cdots are used as capping agents
Is there a method to know how many cdots have attached quantitatively
I would like to ask about a suitable protocol for synthesis of chitosan/siRNA complex and should it include poloxamer 188 as a stabilizer or not. Can I use poloxamer 407 instead?
I want to attach my drug having carboxyl grp with BSA protected Au-25 nanoclusters using EDC-NHS. What concentrations of drug, nanoclusters and EDC-NHS should I take??? Also, is it possible to bind the two using hydrophobic interactions using SDS to lower surface tension of BSA???? Kindly help me out..
Something that can be used in aqueous media to prevent microorganism growth, and that is does not show UV absorption between 200 - 300 nm?
Actually I am able to synthesis anticancer drug conjugated gold nano particles by using CTAB, but I could not synthesis gold alone so please suggest me good method.
For drugs, we can use the UV Vis spectrophotometry in permeation experiments, but how can the permeation of particles be checked? (Particles are soft, around 200-400 nm)
Can anyone please suggest any paper to do bio distribution of metal nanoparticles using NMR/Mass spectroscopy. Also, please suggest how to prepare the samples for those spectra.
I've done the FRAP assay by using 1 ml of sample extract which resulted in high concentration so can anyone please help me with the correct protocol?
In my lab first we tried to make gold iron nanoparticles but nanoparticles always get aggregated.Now i am looking for a company who sells nanoparticles having iron core with gold shell but could`t able to find any company.Please let me know, if anyone knows a company who do sell and about their service.
I am working with using gold nanoparticles to find sequence specific proteins.For control, I attached the thiolated sequence specific oligo (sequence specific to one dna binding protein) to gold nanoparticle. I transfect the nanoparticle inside the cell but I am getting lot of noise. I am getting many non specific protein attached to my nanoparticle only. I did the MS . It has 135 proteins including albumin of serum media. I heard of innovacoat of innova biosciences in which there coating material will not react to any protein inside the cell and proteins will bind to my oligo.Is there any thing like that or any protocol of coating nanoaprticle. I am confused. Help please.
I have developed a nanoformulation for hepatic carcinoma. Now i'm going for cell line studies. I would like to know if the results of liver cancer cell line studies are enough or it is important to carry out in-vivo studies on rats.
I am working on Human Aortic Smooth Muscle Cells (HASMC). Upon confluence when I change the media of Human Aortic Smooth Muscle Cells (HASMC) and wash with PBS, these cells detach from the surface making sheet like structure, If anyone has experience with these cells kindly let me know how I can overcome this problem and reduce the detachment of SMC during washing and media refreshing.
I want to use peppermint oil and lemon oil as a core for nanocapsule preparation.
I would like to know several methods but not processes involved in chitosan to chitosan nanoparticle.
Thank you
How can I compute the volumes of the cavity and trapped unit(s) for the calculation of the 'packing coefficient' for MOF, nanocapsules, etc?
We are planning to scale up (lab-to-industry) lipid based nano injectable systems. Kindly suggest what sort of processing equipment/technology (Microfluidizer? or any other?) helps meets the criteria like reproducibility and bulk manufacturing? Thanks a ton.
Polysaccharides nanoparticle, plant based nanoparticles, drug delivery techniques.
Thank you.
What is the best way or technique to measure the concentration of 20 nm gold nanoparticles per gram of brain areas tissues ?
I want to maintain my gold nanoparticles that produced with bacteria. Please suggest me a suitable way for their maintenance that prevent their aggregations.
Then please suggest me a solvent too.
I am planning to synthesize a nanoparticles using organic molecules and study its anticancer activity. If anyone have suitable references for synthesis, please help me in this regard. Thank you.
I'm raising this question on the behalf of my colleague. She is working on nano composite material synthesis.She wanted to check anti-microbial activity of the composite. Whenever, she prepares the sample, it gets settled down. So, she performed sonication before loading into the wells. But still the substances are not dissolved properly. Can someone tell me how to fix this? Any other methods are available to dissolve this?
What are the various routes they take to enter cells?
Like they may enter through ion channels or by some other physical ways
My polymer is PLGA (65:35) and dichloromethane is the organic solvent, I am using 1% PVA as stabiliser and probe-sonicator to prepare the emulsion. After I prepare the emulsion I stirred the sample for 8 hours however the solution is still milky!!!! is this normal!!!! there is no smell for the organic solvent but I am worry from the appearance of the final solution, any suggestion?
Is it possible to distinguish between silver ions and silver nano-particles distribution in vivo via an imaging method or a combination? Please let me know, for now I only can find x-ray methods for imaging the particle distribution.
Hello all, I know its a far shot but,
I have few human PD brain slices that are fixed on to glass slides, I have to do an IHC and check for Nanoparticle toxicity. Is there any IHC marker or a protein that can be used to evaluate the presence of NP's i.e. If the patient was exposed to some sort of nanoparticles so that i can support the data i have on in-vitro with in-vivo.
Any suggestion is welcome.